US/Silver Spring:
Teva Pharmaceuticals USA, a Parsippany-Troy Hills, New Jersey establishment, recalls all current batch/lots of Amlodipine/Valsartan Combination Tablets and Amlodipine/Valsartan/Hydrochlorothiazide Combination Tablets due to suspected contamination N-nitroso-diethylamine (“NDEA”) a probable human carcinogen., all serious health and safety hazards.
Direct link: https://www.fda.gov/Safety/Recalls/ucm626802.htm
Additional information:
The US Food and Drug Administration (“FDA”) reports the following drugs are subject to this recall:
Filed under: Carcinogen (Cancer-causing), Drugs, US FDA | Tagged: Amlodipine / Valsartan / Hydrochlorothiazide combination Tablets, Amlodipine / Valsartan combination Tablets, Anaphylaxis hazard, Carcinogen (Cancer-causing), FDA, Mylan India, Recalls Direct RIN: 10898-2018, Teva Pharmaceuticals USA, US Food and Drug Administration, Valsartan | Leave a comment »